SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-001230
Filing Date
2021-01-14
Accepted
2021-01-14 17:15:13
Documents
4
Period of Report
2021-01-14
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vtvt-8k_20210114.htm 8-K 31700
2 EX-5.1 vtvt-ex51_6.htm EX-5.1 14027
3 GRAPHIC gfct4cj5u2jy000002.jpg GRAPHIC 3494
4 GRAPHIC gfct4cj5u2jy000001.jpg GRAPHIC 74673
  Complete submission text file 0001564590-21-001230.txt   154873
Mailing Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265
Business Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

IRS No.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37524 | Film No.: 21529614
SIC: 2834 Pharmaceutical Preparations